Inventor · disambiguated record
Stephen R. Jaspers
Also filed as: JASPERS STEPHEN · JASPERS STEPHEN R
56 granted patents·36 pending applications·616 citations·filing 1995–2023
99Inventor score
Top patents by PatentIndex Score
92 records- 0197US7910703B2Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of useZYMOGENETICS INC·Filed 2008·Granted Mar 22, 2011·46 cites·14 claims
- 0297US7790163B2Antibodies that bind both IL-17A and IL-17F and methods of using the sameZYMOGENETICS INC·Filed 2007·Granted Sep 7, 2010·48 cites·7 claims
- 0395US8333968B2Methods of inhibiting inflammation with antagonists to IL-17A, IL-17F, and IL-23P19LEWIS KATHERINE E·Filed 2011·Granted Dec 18, 2012·30 cites·14 claims
- 0495US6709659B1Antibodies that bind testis-specific insulin homolog polypeptidesZYMOGENETICS INC·Filed 2000·Granted Mar 23, 2004·52 cites·19 claims
- 0593US8496936B2Antagonists of IL-17A, IL-17F, and IL-23P19LEWIS KATHERINE E·Filed 2012·Granted Jul 30, 2013·19 cites·2 claims
- 0693US6420521B1Short gastrointestinal peptidesZYMOGENETICS INC·Filed 2000·Granted Jul 16, 2002·27 cites·11 claims
- 0792US7910540B2Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammationZYMOGENETICS INC·Filed 2005·Granted Mar 22, 2011·17 cites·6 claims
- 0892US7655447B2ZSIG33-like polynucleotidesZYMOGENETICS INC·Filed 2008·Granted Feb 2, 2010·11 cites·25 claims
- 0992US6897286B2Zsig33-like peptidesZYMOGENETICS INC·Filed 2001·Granted May 24, 2005·22 cites·13 claims
- 1091US8609099B2Antibodies that bind both IL-17A and IL-17FJASPERS STEPHEN R·Filed 2010·Granted Dec 17, 2013·12 cites·3 claims
- 1191US8557544B2Polynucleotides encoding antibodies that bind both IL-17A and IL-17FJASPERS STEPHEN R·Filed 2012·Granted Oct 15, 2013·11 cites·8 claims
- 1291US5959075ATestis-specific insulin homolog polypeptidesZYMOGENETICS INC·Filed 1997·Granted Sep 28, 1999·86 cites·8 claims
- 1389US8871467B2Polynucleotides encoding antibodies that bind both IL-17A and IL-17FZYMOGENETICS INC·Filed 2013·Granted Oct 28, 2014·7 cites·4 claims
- 1489US8268773B2Methods of treating multiple sclerosis (MS) using an IL-17A and IL-17F antagonistPRESNELL SCOTT R·Filed 2011·Granted Sep 18, 2012·12 cites·6 claims
- 1589US7445919B2Zsig33-like peptides and polynucleotidesZYMOGENETICS INC·Filed 2004·Granted Nov 4, 2008·12 cites·16 claims
- 1688US9388241B2Anti-human IL-21 antibodiesSIVAKUMAR PALLAVUR V·Filed 2012·Granted Jul 12, 2016·8 cites·6 claims
- 1788US8992922B2Antagonists of IL-17A, IL-17F, and IL-23P19ZYMOGENETICS INC·Filed 2013·Granted Mar 31, 2015·7 cites·3 claims
- 1888US7923539B2IL-21 antagonistsZYMOGENETICS INC·Filed 2008·Granted Apr 12, 2011·7 cites·9 claims
- 1988US7704950B2Methods of using soluble heterodimeric cytokine receptorZYMOGENETICS INC·Filed 2007·Granted Apr 27, 2010·8 cites·11 claims
- 2088US6838438B2Motilin HomologsZYMOGENETICS INC·Filed 2001·Granted Jan 4, 2005·15 cites·10 claims
- 2187US7592427B2Antibodies to IL-21 receptorZYMOGENETICS INC·Filed 2006·Granted Sep 22, 2009·7 cites·5 claims
- 2284US6361985B1Beta-1,3-galactosyltransferase homolog, ZNSSP6ZYMOGENETICS INC·Filed 2000·Granted Mar 26, 2002·10 cites·13 claims
- 2383US6939690B2Polynucleotides encoding motilin homologsZYMOGENETICS INC·Filed 2001·Granted Sep 6, 2005·8 cites·16 claims
- 2482US9464134B2Polynucleotides encoding antagonists of IL-17A, IL-17F, and IL-23p19ZYMOGENETICS INC·Filed 2015·Granted Oct 11, 2016·2 cites·5 claims
- 2581US7883700B2Anti-human IL-21 monoclonal antibodiesZYMOGENETICS INC·Filed 2008·Granted Feb 8, 2011·3 cites·6 claims
- 2680US8222374B2IL-21 antagonistsSIVAKUMAR PALLAVUR V·Filed 2011·Granted Jul 17, 2012·3 cites·6 claims
- 2780US6114307AMethods for stimulating pancreatic islet cell regenerationZYMOGENETICS INC·Filed 1997·Granted Sep 5, 2000·36 cites·8 claims
- 2878US9994634B2Use of an IL-17/IL-23 bispecific antibody for treating inflammationZYMOGENETICS INC·Filed 2016·Granted Jun 12, 2018·1 cites·4 claims
- 2978US2023416384A1Methods of treating severe insulin resistance by interfering with glucagon receptor signalingREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 3076US9416183B2Methods of treating inflammatory diseases using antibodies that bind both IL-17A and IL-17FZYMOGENETICS INC·Filed 2014·Granted Aug 16, 2016·1 cites·6 claims
- 3176US6416988B1Beta-1,3-galactosyltransferase homologsZYMOGENETICS INC·Filed 1999·Granted Jul 9, 2002·29 cites·7 claims
- 3275US8790643B2Methods for treating disease using an anti-IL-21 receptor antibodySIVAKUMAR PALLAVUR V·Filed 2010·Granted Jul 29, 2014·2 cites·15 claims
- 3374US8124089B2Anti-human IL-21 monoclonal antibodiesJASPERS STEPHEN R·Filed 2009·Granted Feb 28, 2012·1 cites·23 claims
- 3473US11708416B2Methods of treating severe insulin resistance by interfering with glucagon receptor signalingREGENERON PHARMA·Filed 2021·Granted Jul 25, 2023·0 cites·11 claims
- 3573US6627729B1TML peptidesZYMOGENETICS INC·Filed 1999·Granted Sep 30, 2003·24 cites·11 claims
- 3672US8361470B2Methods of treatment using anti-human IL-21 monoclonal antibodiesZYMOGENETICS INC·Filed 2012·Granted Jan 29, 2013·1 cites·18 claims
- 3772US8241629B2Anti-human IL-21 monoclonal antibodiesJASPERS STEPHEN R·Filed 2010·Granted Aug 14, 2012·1 cites·11 claims
- 3872US8226948B1Anti-human IL-21 monoclonal antibodiesJASPERS STEPHEN R·Filed 2012·Granted Jul 24, 2012·1 cites·8 claims
- 3971US2008194484A1TML polynucleotidesZYMOGENETICS INC·Filed 2008·Application pending·0 cites
- 4071US2011097331A1Antibodies that bind both il-17a and il-17f and methods of using the sameZYMOGENETICS INC·Filed 2009·Application pending·0 cites
- 4170US10640575B2Use of IL-17A and IL-17F cross-reactive monoclonal antibodies for treating inflammatory diseasesZYMOGENETICS INC·Filed 2018·Granted May 5, 2020·0 cites·3 claims
- 4270US7977309B2Methods of using motilin homologsZYMOGENETICS INC·Filed 2008·Granted Jul 12, 2011·0 cites·2 claims
- 4370US7855269B2Method for treating inflammationZYMOGENETICS INC·Filed 2001·Granted Dec 21, 2010·3 cites·1 claims
- 4468US10562967B2Treating inflammation with IL-17/IL-23 bispecific antibodiesZYMOGENETICS INC·Filed 2018·Granted Feb 18, 2020·0 cites·4 claims
- 4567US10023656B2Methods of treating inflammation using IL-17A and IL-17F cross-reactive monoclonal antibodiesZYMOGENETICS INC·Filed 2017·Granted Jul 17, 2018·0 cites·10 claims
- 4667US2018251543A1Polynucleotides encoding monoclonal antibodies that bind both il-17a and il-17fZYMOGENETICS INC·Filed 2018·Application pending·0 cites
- 4767US2005106146A1Antibodies to motilin homologsFiled 2004·Application pending·0 cites
- 4865US7354739B2TML polynucleotidesZYMOGENETICS INC·Filed 2003·Granted Apr 8, 2008·0 cites·6 claims
- 4965US2010008915A1Methods for treating disease using an anti-il-21 receptor antibodyZYMOGENETICS INC·Filed 2009·Application pending·0 cites
- 5064US10000563B2Monoclonal antibodies that bind both IL-17A and IL-17FZYMOGENETICS INC·Filed 2016·Granted Jun 19, 2018·0 cites·3 claims
Showing the top 50 of 92 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Stephen R. Jaspers files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →